Tocotrienol Completed Phase 2 Trials for Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02399592Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer